FDA schedules SARS (severe acute respiratory syndrome) strategy meeting for July:
This article was originally published in Clinica
The FDA will hold a public workshop on July 14 to discuss methods for evaluating new diagnostic tests for severe acute respiratory syndrome (SARS). The meeting will begin at 8am at the Double Tree, Rockville Hotel, Rockville, Maryland. Pre-registration is required by July 7 and will be accepted on a first-come, first-served basis. Register online at www.fda.gov/cdrh/meetings/071403 or on tel: +1 888 203 6161.